FEVAX | FTSDX | FEVAX / FTSDX | |
Total Expense Ratio | 1.15 | 1.17 | 98% |
Annual Report Gross Expense Ratio | 1.15 | 1.17 | 98% |
Fund Existence | 24 years | 21 years | - |
Gain YTD | 8.128 | 3.080 | 264% |
Front Load | 5% | 4% | 143% |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.46B | 5.13B | 28% |
Annual Yield % from dividends | 1.49 | 1.99 | 74% |
Returns for 1 year | 9.74 | 6.54 | 149% |
Returns for 3 years | 25.09 | 21.13 | 119% |
Returns for 5 years | 45.13 | 33.52 | 135% |
Returns for 10 years | 16.87 | 36.94 | 46% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LSGRX | 30.53 | -0.26 | -0.84% |
Loomis Sayles Growth Y | |||
CVLOX | 12.83 | -0.11 | -0.85% |
Calamos Global Opportunities A | |||
GFVAX | 15.25 | -0.20 | -1.29% |
Goldman Sachs Focused Value A | |||
RMQHX | 538.07 | -13.88 | -2.51% |
Rydex Monthly Rbl NASDAQ-100® 2x Strt H | |||
NMSCX | 20.38 | -1.27 | -5.87% |
Columbia Small Cap Index Inst |